live attenuated bacterial vaccine protects typhoid first licensed europe united states orally administered liveattenuated strain typhi multiple genes including genes responsible production vi deleted render harmless nevertheless immunogenic one three typhoid vaccines currently recommended world health organization two typhoid conjugate vaccine tcv vi capsular polysaccharide vaccine given mouth vaccine presented either enteric coated capsules liquid suspension vaccine must stored retain potency days vaccine offers statistically significant protection first seven vaccine commonly used protect travelers endemic countries agencies claim vaccine could used large scale public prevention vi polysaccharide vaccine also effective preventing typhoid recommended dose varies according country preparation least three doses required us canada initial course doses alternate days recommended full protection achieved days last dose us booster dose recommended years canada booster dose recommended yearscitation needed australia europe initial course doses alternate days recommended protection achieved days last dose booster dose recommended every years people living endemic areas every year people traveling nonendemic endemic side effects vaccine mild may also provide degree protection paratyphoid fever crossprotection typhoid vaccine likely due antigens shared different enterica newer virepa vaccine tested preventing typhoid fever similar level protection protection may last longer newer article vaccines vaccination stub help wikipedia expanding